Invention Grant
- Patent Title: Enhancement of GLP-2 activity of suppressing appetite
- Patent Title (中): 增强抑制食欲的GLP-2活性
-
Application No.: US10829201Application Date: 2004-04-22
-
Publication No.: US07862824B2Publication Date: 2011-01-04
- Inventor: Daniel J. Drucker , Julie Ann Louise Lovshin
- Applicant: Daniel J. Drucker , Julie Ann Louise Lovshin
- Applicant Address: CA Toronto, ON
- Assignee: 1149336 Ontario, Inc.
- Current Assignee: 1149336 Ontario, Inc.
- Current Assignee Address: CA Toronto, ON
- Agency: Stoel Rives LLP
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K38/26
Abstract:
The effects of GLP-2 are enhanced using a GLP-1 activity inhibitor. For medical use to treat or inhibit the onset of medical conditions, disorder or diseases for which treatment with GLP-2 is indicated, the present invention provides a pharmaceutical combination comprising a GLP-2 activity enhancer, and a GLP-1 activity inhibitor. The combination is useful particularly to treat gastrointestinal conditions such as small bowel syndrome, mucositis and Crohn's disease, and to suppress appetite, for instance to treat obesity.
Public/Granted literature
- US20040198642A1 Enhancement of GLP-2 activity Public/Granted day:2004-10-07
Information query
IPC分类:
